Parallelism and non-parallelism in diabetic nephropathy and diabetic retinopathy

Front Endocrinol (Lausanne). 2024 Feb 14:15:1336123. doi: 10.3389/fendo.2024.1336123. eCollection 2024.

Abstract

Diabetic nephropathy (DN) and diabetic retinopathy (DR), as microvascular complications of diabetes mellitus, are currently the leading causes of end-stage renal disease (ESRD) and blindness, respectively, in the adult working population, and they are major public health problems with social and economic burdens. The parallelism between the two in the process of occurrence and development manifests in the high overlap of disease-causing risk factors and pathogenesis, high rates of comorbidity, mutually predictive effects, and partial concordance in the clinical use of medications. However, since the two organs, the eye and the kidney, have their unique internal environment and physiological processes, each with specific influencing molecules, and the target organs have non-parallelism due to different pathological changes and responses to various influencing factors, this article provides an overview of the parallelism and non-parallelism between DN and DR to further recognize the commonalities and differences between the two diseases and provide references for early diagnosis, clinical guidance on the use of medication, and the development of new drugs.

Keywords: diabetic nephropathy; diabetic retinopathy; mechanism; non-parallelism; parallelism.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Diabetes Mellitus*
  • Diabetic Nephropathies* / pathology
  • Diabetic Retinopathy* / pathology
  • Humans
  • Kidney / pathology
  • Kidney Failure, Chronic*

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was supported by the National Multidisciplinary Interdisciplinary Innovation Team Project of Traditional Chinese Medicine (ZYYCXTD-D-202001), the Science and Technology Innovation Project of the China Academy of Traditional Chinese Medicine (C12021A02610), the National Natural Science Foundation of China under the Young Science Foundation Project (82305205), and the Clinical Research Center Construction Project of the Guang’anmen Hospital of the China Academy of Traditional Chinese Medicine (Approval No. 2022LYJSZX01~2022LYJSZX29).